US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

The Gabelli Multimedia Trust Inc.

4.27

-0.0500-1.16%

Post-market: 4.270.00000.00%17:37 EDT

Volume:149.62K

Turnover:643.70K

Market Cap:144.58M

PE:11.69

High:4.34

Open:4.32

Low:4.27

Close:4.32

Loading ...

Overview Company News Filings

GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025

STEPN creator FSL launches GMT Pay, letting users spend crypto anywhere 6 seconds ago

Late-breaking elafibranor primary sclerosing cholangitis (PSC) data demonstrates favorable safety profile and significant efficacy in second potential rare liver disease indication

BRIEF-Gabelli Multimedia Trust Enters Sales Agreement To Sell Up To 5 Mln Shares

Gabelli Multimedia Trust Inc - on April 16, Enters Sales Agreement to Sell up to 5 Mln Shares - SEC Filing

THOMSON REUTERS

Press Release: Gabelli Multimedia Trust Board Approves at the Market Common Stock Offerings With Prices Trading Above NAV

Gabelli Multimedia Trust Reinforces Maintenance of $0.88 Per Share Annual Distribution Will Commence Monthly Distributions in May 2025

Press Release: MetaVia Reports Year End 2024 Financial Results and Provides Corporate Update

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003

UPDATE - United Kingdom Investment Trusts

Discount Doctor to Visit United Kingdom in Support of Investment Trusts

MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH

Gilead’s Seladelpar Receives Positive CHMP Opinion for Primary Biliary Cholangitis

Daiichi Sankyo to Showcase TURALIO® Research in Patients with Tenosynovial Giant Cell Tumor at CTOS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GGT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GGT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GGT\",,,,,undefined,":{"symbol":"GGT","market":"US","secType":"STK","nameCN":"The Gabelli Multimedia Trust Inc.","latestPrice":4.27,"timestamp":1746820800000,"preClose":4.32,"halted":0,"volume":149615,"hourTrading":{"tag":"盘后","latestPrice":4.27,"preClose":4.27,"latestTime":"17:37 EDT","volume":9,"amount":38.71,"timestamp":1746826629322},"delay":0,"floatShares":0,"shares":33858400,"eps":0.365306,"marketStatus":"Market Closed","change":-0.05,"latestTime":"05-09 16:00:00 EDT","open":4.32,"high":4.336175,"low":4.27,"amount":643695.392059,"amplitude":0.015318,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.365306,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1747036800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":4.32,"dividendRate":0.206089,"preHourTrading":{"tag":"盘前","latestPrice":4.35,"preClose":4.32,"latestTime":"09:17 EDT","volume":10,"amount":43.5,"timestamp":1746796655695},"postHourTrading":{"tag":"盘后","latestPrice":4.27,"preClose":4.27,"latestTime":"17:37 EDT","volume":9,"amount":38.71,"timestamp":1746826629322},"volumeRatio":1.310605},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GGT\",,,,,undefined,":{"symbol":"GGT","floatShares":0,"roa":"0.18%","roe":"8.55%","lyrEps":0.365306,"volumeRatio":1.310605,"shares":33858400,"dividePrice":0.88,"high":4.336175,"amplitude":0.015318,"preClose":4.32,"low":4.27,"week52Low":4,"pbRate":"1.24","psRate":"46.02","week52High":5.98,"institutionHeld":0.216,"latestPrice":4.27,"eps":0.365306,"divideRate":0.206089,"volume":149615,"delay":0,"ttmEps":0.365306,"open":4.32,"prevYearClose":4.46,"prevWeekClose":4.46,"prevMonthClose":4.48,"prevQuarterClose":4.63,"fiveDayClose":4.46,"twentyDayClose":4.28,"sixtyDayClose":4.82},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GGT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531266914","title":"GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2531266914","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531266914?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:10","pubTimestamp":1745871000,"startTime":"0","endTime":"0","summary":"Lille , Cambridge , Zurich , April 28, 2025 - GENFIT , a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announced that Ipsen will be presenting data from its late-breaking abstract on elafibranor, highlighting favorable safety profile and significant efficacy in Primary Sclerosing Cholangitis , at the European Association for the Study of the Liver  on May 10, 2025 at 11.15 CET.Pascal Prigent, CEO of GENFIT, commented: “We continue to be very pleased with Ipsen’s commitment to developing elafibranor, and the results from the ELMWOOD Phase 2 trial further reinforce our belief in elafibranor’s potential to address serious liver diseases.”ABOUT PSCPSC is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts, which can lead to liver damage and eventually liver failure. The exact cause of PSC is unknown, but it is often associated with other autoimmune conditions, such as inflam","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genfit-positive-breaking-phase-2-201000577.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1559883803.SGD","USA","EC","LU1242518857.USD","LU1242518931.SGD","LU0053671581.USD","BK4139","PBC","BK4201","PSC","GGT","LU0566484027.USD","BK4599","ELF","LU1878469433.USD","CCA","BK4588","BK4585","LU0979878070.USD","BK4183","GNFT","GNFTF","ALT"],"gpt_icon":0},{"id":"2531423239","title":"STEPN creator FSL launches GMT Pay, letting users spend crypto anywhere                \n\n6 seconds ago","url":"https://stock-news.laohu8.com/highlight/detail?id=2531423239","media":"cryptonews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531423239?lang=en_us&edition=fundamental","pubTime":"2025-04-29 00:16","pubTimestamp":1745856991,"startTime":"0","endTime":"0","summary":"The company behind the STEPN move-to-earn app partnered with MasterCard, enabling users to spend GMT tokens almost anywhere.Crypto projects are stepping up their integration with traditional finance. On April 28, FSL, the Web3 firm behind the move-to-earn app STEPN , partnered with MasterCard to launch its own GMT Pay network. The card will enable users to use their GMT and GGT tokens directly for purchases, anywhere in the world.Turn your crypto into real-world spending power with the GMT Pay app – available now for everyone!Instant card activation Global availability Apple Pay & Google Pay compatibleWatch your rewards from @stepnofficial transform into real-life value…Specifically, the company is launching the GMT Pay Gift Card, available in $50, $100, $200, and $300 denominations. Users can use the virtual card, powered by MasterCard, for both online and offline purchases, and add it to Apple Pay or Google Pay.At the same time, the GMT card is available to users worldwide. While FSL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://crypto.news/stepn-creator-fsl-launches-gmt-pay-letting-users-spend-crypto-anywhere/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"crypto_news_highlight","symbols":["APT.USD.HKCC","TON.USD.HKCC","GGT","TON.USD.CC","APT.USD.CC"],"gpt_icon":0},{"id":"2529647669","title":"Late-breaking elafibranor primary sclerosing cholangitis (PSC) data demonstrates favorable safety profile and significant efficacy in second potential rare liver disease indication","url":"https://stock-news.laohu8.com/highlight/detail?id=2529647669","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529647669?lang=en_us&edition=fundamental","pubTime":"2025-04-24 14:14","pubTimestamp":1745475240,"startTime":"0","endTime":"0","summary":"Elafibranor showed a favorable safety profile and demonstrated dose-dependent efficacy over 12 weeks for people living with PSC, a rare liver disease that currently has no approved treatment options. Patients treated with elafibranor versus placebo showed significant improvements in liver biochemical parameters, including alkaline phosphatase . Stabilization of non-invasive markers of liver fibrosis were observed in patients on elafibranor versus placebo. PARIS, FRANCE, 24 April 2025 Ipsen  will be presenting data from the late-breaking abstract on elafibranor in the investigational Phase II ELMWOOD study at the European Association for the Study of the Liver  congress as an oral presentation, on 10 May at 11.15 CET. For the first time data highlighting the potential of elafibranor in treating people living with primary sclerosing cholangitis  will be presented. PSC is a rare liver disease that currently has no approved treatment options.Patients on elafibranor also had stabilization i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/breaking-elafibranor-primary-sclerosing-cholangitis-061400283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LU1878469433.USD","PBC","PSC","LU0566484027.USD","BK4588","ELF","LU0053671581.USD","LU0979878070.USD","EC","BK4183","ALT","LU1242518931.SGD","LU1559883803.SGD","BK4585","LU1242518857.USD","BK4007","IPSEY","BK4599","GGT","IPSEF","BK4201"],"gpt_icon":0},{"id":"2529068550","title":"BRIEF-Gabelli Multimedia Trust Enters Sales Agreement To Sell Up To 5 Mln Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2529068550","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529068550?lang=en_us&edition=fundamental","pubTime":"2025-04-23 04:55","pubTimestamp":1745355308,"startTime":"0","endTime":"0","summary":"BRIEF-Gabelli Multimedia Trust Enters Sales Agreement To Sell Up To 5 Mln Shares April 22  - Gabelli Multimedia Trust Inc GGT.N:GABELLI MULTIMEDIA TRUST INC - ON APRIL 16, ENTERS SALES AGREEMENT TO SELL UP TO 5 MILLION SHARES - SEC FILINGSource text: [ID:n0001999371-25-004540]Further company coverage: GGT.N ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nFWN3R02K1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GGT"],"gpt_icon":0},{"id":"2529155257","title":"Gabelli Multimedia Trust Inc - on April 16, Enters Sales Agreement to Sell up to 5 Mln Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2529155257","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529155257?lang=en_us&edition=fundamental","pubTime":"2025-04-23 04:22","pubTimestamp":1745353328,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250422:nFWN3R02K1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GGT"],"gpt_icon":0},{"id":"2526469523","title":"Press Release: Gabelli Multimedia Trust Board Approves at the Market Common Stock Offerings With Prices Trading Above NAV","url":"https://stock-news.laohu8.com/highlight/detail?id=2526469523","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526469523?lang=en_us&edition=fundamental","pubTime":"2025-04-10 05:00","pubTimestamp":1744232400,"startTime":"0","endTime":"0","summary":"RYE, N.Y., April 09, 2025  -- The Board of Directors of The Gabelli Multimedia Trust Inc.   has authorized the Fund to conduct offerings of common stock in \"at the market\" transactions ,at prices above the net asset value, which would be accretive to the common shares.The Board of Directors will continue to evaluate the Fund's capital structure, including the ability for shareholders to subscribe for additional common stock. The Fund has previously completed six rights offerings.The ATM offering will be made pursuant to the Fund's currently effective shelf registration statement on file with the Securities and Exchange Commission  and only by means of a prospectus supplement and accompanying prospectus. A final prospectus supplement and accompanying prospectus will be filed with the SEC, but has not been filed as of the date hereof.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","GAMI","GGT","NAV"],"gpt_icon":0},{"id":"2526126433","title":"Gabelli Multimedia Trust Reinforces Maintenance of $0.88 Per Share Annual Distribution Will Commence Monthly Distributions in May 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2526126433","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526126433?lang=en_us&edition=fundamental","pubTime":"2025-04-10 02:54","pubTimestamp":1744224840,"startTime":"0","endTime":"0","summary":"RYE, N.Y., April  09, 2025  (GLOBE NEWSWIRE) -- The Board of Directors of The Gabelli Multimedia Trust Inc. (NYSE: GGT) (the “Fund”) has determined to begin monthly distributions to the common stock s","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/09/3058815/0/en/Gabelli-Multimedia-Trust-Reinforces-Maintenance-of-0-88-Per-Share-Annual-Distribution-Will-Commence-Monthly-Distributions-in-May-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","GGT","GAMI"],"gpt_icon":0},{"id":"2520458331","title":"Press Release: MetaVia Reports Year End 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2520458331","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520458331?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:31","pubTimestamp":1742470260,"startTime":"0","endTime":"0","summary":"Top-Line Data From MAD Part 2 of the Phase 1 Trial of DA-1726 Expected in April of 2025. Announced Positive Top-Line 16-Week Results from the Phase 2a Trial of DA-1241 for the Treatment of MASH, in December, Demonstrating Direct Hepatic Action in Addition to Its Glucose Lowering Effect. $16.0 Million in Cash at End of Fourth Quarter Expected to Fund the Company Into the Third Quarter of 2025. CAMBRIDGE, Mass., March 20, 2025 /PRNewswire/ -- MetaVia Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the year ended December 31, 2024 and provided a corporate strategic update.Mr. Kim continued, \"In December, we reported positive top-line 16-week results from the two-part Phase 2a clinical trial of DA-1241, a novel G-Protein-Coupled Receptor 119  agonist, in patients with presumed metabolic dysfunction-associated steatohepatitis . DA-1241 met the primary endpoint, achieving a reduction in alanine transaminase","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4202","BK4139","GGT","LU1878469433.USD","OXM","BK4599","ALT"],"gpt_icon":0},{"id":"2514898508","title":"Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514898508","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514898508?lang=en_us&edition=fundamental","pubTime":"2025-02-27 05:01","pubTimestamp":1740603660,"startTime":"0","endTime":"0","summary":"- 2025 expected global net product sales of $420 million to $435 million. - VISTAS study of volixibat in PSC expected to complete enrollment in second half 2025; topline data expected 2026. - CTEXLI  approved in the US for cerebrotendinous xanthomatosis. - Conference call to provide business updates today, February 26 at 1:30 p.m. PT/4:30 p.m. ET. FOSTER CITY, Calif., February 26, 2025----Mirum Pharmaceuticals, Inc.  today reported financial results for the fourth quarter and year-end 2024 and provided a business update.\"2024 was another year of significant growth and accomplishments for Mirum and in 2025 we expect this momentum to continue,\" said Chris Peetz, chief executive officer of Mirum. \"We continue to expand the reach of our three commercial medicines within our patient communities and look forward to another year of strong financial performance. On top of this, we are looking forward to multiple upcoming clinical and regulatory milestones, such as PSC where we’re expecting ful","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mirum-pharmaceuticals-reports-fourth-quarter-210100952.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALGS","BK4516","IBAT","BK4588","GGT","FXS","FSV","BK4599","PSC","LU1878469433.USD","BSEP","BK4139","ALT","X","BK4006","PBC","MIRM","BK4532","BK4520","BK4079","BK4505","BK4585"],"gpt_icon":1},{"id":"2512156537","title":"Solid Biosciences Reports Positive Initial Clinical Data from Next-Generation Duchenne Gene Therapy Candidate SGT-003","url":"https://stock-news.laohu8.com/highlight/detail?id=2512156537","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512156537?lang=en_us&edition=fundamental","pubTime":"2025-02-18 19:45","pubTimestamp":1739879100,"startTime":"0","endTime":"0","summary":"— Day 90 biopsy data reported from first 3 participants dosed in Phase 1/2 INSPIRE DUCHENNE trial ——Average microdystrophin expression of 110% (N=3) and significant improvements in multiple additional","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/18/3027621/0/en/Solid-Biosciences-Reports-Positive-Initial-Clinical-Data-from-Next-Generation-Duchenne-Gene-Therapy-Candidate-SGT-003.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AST","ALT","BK4130","LU1878469433.USD","BK4599","AESI","GGT","SLDB","BK4139","BK4539","BK4179","BK4535","FA"],"gpt_icon":0},{"id":"2507669366","title":"UPDATE - United Kingdom Investment Trusts","url":"https://stock-news.laohu8.com/highlight/detail?id=2507669366","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507669366?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:35","pubTimestamp":1738186500,"startTime":"0","endTime":"0","summary":"GREENWICH, Conn., Jan. 29, 2025  -- Closed-End – David Schachter, Senior Vice President of Gabelli Funds, will travel to the United Kingdom to visit selected investment trusts.With over 40 years of experience exclusively with retail, long term, closed-end fund investors, Mr. Schachter, a most senior and experienced veteran of the U.S. Closed-End Fund industry, is also Vice President of The GAMCO Natural Resources, Gold & Income Trust , which trades on the NYSE.During the 19th century, capital was raised through closed-end funds. These funds helped build the railroads, which linked the American continent from sea to sea and led to the nation’s economic success.A Fund’s NAV per share will fluctuate with changes in the market value of the Fund’s portfolio securities. Stocks are subject to market, economic, and business risks that cause their prices to fluctuate. Investors acquire shares of the Fund on a securities exchange at market value, which fluctuates according to the dynamics of sup","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/united-kingdom-investment-trusts-213500560.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GGN","BK4211","GCV","GDL","GGT","ECF","UBCP","GDV","GNT","BCV","GGZ","GRX","GUT","GLU","GAB","AIC"],"gpt_icon":0},{"id":"2507232665","title":"Discount Doctor to Visit United Kingdom in Support of Investment Trusts","url":"https://stock-news.laohu8.com/highlight/detail?id=2507232665","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507232665?lang=en_us&edition=fundamental","pubTime":"2025-01-29 04:34","pubTimestamp":1738096440,"startTime":"0","endTime":"0","summary":"RYE, N.Y., Jan. 28, 2025  -- David Schachter, Senior Vice President of GAMCO Investors, Inc., will visit the United Kingdom to convey support for the British investment trust industry.With over 40 years of experience exclusively with retail, long term, closed-end fund investors, Mr. Schachter, a most senior and experienced veteran of the U.S. Closed End Fund industry, was recently given the title of Discount Doctor by the Trustees of The GAMCO Natural Resources, Gold & Income Trust , which trades on the NYSE.Gabelli Funds, LLC is the adviser to thirteen closed-end funds which trade on the NYSE: Gabelli Equity Trust , Gabelli Convertible & Income Securities Fund , Gabelli Multimedia Trust , Gabelli Utility Trust , Gabelli Dividend & Income Trust , Gabelli Global Utility & Income Trust , GAMCO Global Gold Natural Resources & Income Trust , The GDL Fund , Gabelli Healthcare & WellnessRX Trust , GAMCO Natural Resources, Gold & Income Trust , Gabelli Global Small and Mid-Cap Value Trust , B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/discount-doctor-visit-united-kingdom-203400243.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BCV","GAB","GCV","GNT","UBCP","GLU","GGT","GUT","GGZ","BK4211","GDL","GDV","GRX","GGN","AIC","ECF"],"gpt_icon":0},{"id":"2492183515","title":"MetaVia Announces Positive Top-Line Results From Its Phase 2a Clinical Trial of DA-1241 in Patients with Presumed MASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2492183515","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492183515?lang=en_us&edition=fundamental","pubTime":"2024-12-18 21:01","pubTimestamp":1734526860,"startTime":"0","endTime":"0","summary":"DA-1241 Demonstrated Direct Hepatic Action in Addition to Its Glucose Lowering Effect. Patients Treated with DA-1241 100mg Achieved Statistically Significant Reduction in ALT Levels at Weeks 4 and 8, and a Near Statistically Significant Reduction at Week 16. DA-1241 100mg Demonstrated Statistically Significant Improvements in CAP Score at Week 16. Awaiting Data on Other Exploratory Endpoints Including MRI-PDFF. Additional Findings to be Submitted for Upcoming Scientific Conferences. * Confidence interval excludes 0, suggesting a statistically meaningful difference. p < 0.05 vs. placebo. Proportion of Subjects with Normalized ALT <30 IU/L at Week 16. LS Mean CAP, VCTE, FAST score Changes from Baseline at Week 16","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/kgC08qjrpJvbPneNdK27Eg--~B/aD03Nzt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/116597eda2a36d52628a741d23461740","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/kgC08qjrpJvbPneNdK27Eg--~B/aD03Nzt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/116597eda2a36d52628a741d23461740"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/metavia-announces-positive-top-line-130100214.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/metavia-announces-positive-top-line-130100214.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4567","OXM","BK4104","IE00BYQQ9H92.USD","FAST","ALT","MTVA","BK4139","IE00BFXG0V08.USD","BK4599","BK4585","AST","GGT","IE00B5TLWC47.USD","LU1878469433.USD","BK4588","BK4202"],"gpt_icon":0},{"id":"2491214753","title":"Gilead’s Seladelpar Receives Positive CHMP Opinion for Primary Biliary Cholangitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2491214753","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491214753?lang=en_us&edition=fundamental","pubTime":"2024-12-13 19:37","pubTimestamp":1734089820,"startTime":"0","endTime":"0","summary":"– Recommendation Based on the RESPONSE Study Which Demonstrated ALP Normalization in 25% of Participants at 12 Months and Statistically Significant Reduction of Pruritus Versus Placebo –。The positive opinion was supported primarily by data from the pivotal placebo-controlled Phase 3 RESPONSE study. In the study, 62% of participants taking seladelpar achieved the primary endpoint of composite biochemical response at month 12 compared with 20% of participants taking placebo. Treatment with seladelpar led to normalization of ALP values in 25% of trial participants at month 12. This change was not seen in any trial participants receiving placebo. ALP is a cholestatic marker that is a predictor of risk for liver transplant and death. Change from baseline pruritus score at month 6 was a key s","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/pvxf9aCo6mke7xm8sJZyWg--~B/aD01NzY7dz0xNzI4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/86a7735b21854a533ac901b334cc91fe","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/pvxf9aCo6mke7xm8sJZyWg--~B/aD01NzY7dz0xNzI4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/86a7735b21854a533ac901b334cc91fe"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-seladelpar-receives-positive-chmp-113700996.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4087","LU0234570918.USD","BK4528","LU0320765992.SGD","BK4532","LU0289739699.SGD","BK4599","GILD","BK4583","PBC","LU1430594728.SGD","ALT","BK4568","LU0109394709.USD","BK4550","LU1839511570.USD","LU1066051498.USD","LU2087621335.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","IE0002270589.USD","IE00B3T34201.USD","BK4205","CHMP","IE00B7SZLL34.SGD","BK4578","LU1585245621.USD","BK4233","BK4588","BK4566","IE00BSNM7G36.USD","LU1066053197.SGD","LU0889565916.HKD","LU1571399168.USD","IE00B19Z3581.USD","UK","BK4139","BK4585","IE00BKVL7J92.USD","LU2468319806.SGD","LU1878469433.USD","IE00B19Z3B42.SGD","GGT"],"gpt_icon":0},{"id":"2483755002","title":"Daiichi Sankyo to Showcase TURALIO® Research in Patients with Tenosynovial Giant Cell Tumor at CTOS","url":"https://stock-news.laohu8.com/highlight/detail?id=2483755002","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483755002?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:00","pubTimestamp":1731502800,"startTime":"0","endTime":"0","summary":"BASKING RIDGE, N.J., November 13, 2024----Daiichi Sankyo  will highlight new clinical research and real-world data from seven abstracts for TURALIO  at the Connective Tissue Oncology Society  2024 Annual Meeting.TURALIO is the first and only oral systemic therapy approved in the U.S. for adult patients with tenosynovial giant cell tumor  associated with severe morbidity or functional limitations and not amenable to improvement with surgery. TGCT is a rare and typically non-malignant tumor that affects small and large joints.1,2,3. \"These latest data being presented at CTOS continue to support the role of TURALIO as a treatment option for certain patients with tenosynovial giant cell tumor,\" said Dan Switzer, Head of U.S. Oncology Business, Daiichi Sankyo, Inc. \"As a leader in TGCT research and development, Daiichi Sankyo has made significant progress in transforming the treatment landscape for patients with this rare, debilitating tumor and we remain committed to educating the medical ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Q_Ud.j.faz9TGQm1x1aHQg--~B/aD0yODA7dz0yNjc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/0eaf3e57716fb77929dd27bf6662f931","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Q_Ud.j.faz9TGQm1x1aHQg--~B/aD0yODA7dz0yNjc7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/0eaf3e57716fb77929dd27bf6662f931"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/daiichi-sankyo-showcase-turalio-research-130000028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","PST","DSNKY","BK4104","GGT","DSKYF","ALT","LU1878469433.USD","BK4007","CTOS","AST"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GGT\",params:#limit:5,,,undefined,":[{"date":"2025-06-13","symbol":"GGT","amount":0.08,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-13","defaultRemindTime":1749821400000,"name":"GGT全球多媒体基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-23","payableDate":"2025-06-13","currency":"USD","dateTimestamp":1749787200000,"payDate":"2025-06-23"},{"date":"2025-05-15","symbol":"GGT","amount":0.14,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-15","defaultRemindTime":1747315800000,"name":"GGT全球多媒体基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-22","payableDate":"2025-05-15","currency":"USD","dateTimestamp":1747281600000,"payDate":"2025-05-22"},{"date":"2025-03-17","symbol":"GGT","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-17","defaultRemindTime":1742218200000,"name":"GGT全球多媒体基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-24","payableDate":"2025-03-17","currency":"USD","dateTimestamp":1742184000000,"payDate":"2025-03-24"},{"date":"2024-12-13","symbol":"GGT","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"GGT全球多媒体基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-20"},{"date":"2024-09-16","symbol":"GGT","amount":0.22,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-16","defaultRemindTime":1726493400000,"name":"GGT全球多媒体基金","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-23","payableDate":"2024-09-16","currency":"USD","dateTimestamp":1726459200000,"payDate":"2024-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GGT\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-12","recordDate":"2015-06-16","paymentDate":"2015-06-23","value":0.22,"currency":"USD"},{"executeDate":"2015-09-14","recordDate":"2015-09-16","paymentDate":"2015-09-23","value":0.22,"currency":"USD"},{"executeDate":"2015-12-09","recordDate":"2015-12-11","paymentDate":"2015-12-18","value":0.28,"currency":"USD"},{"executeDate":"2016-03-14","recordDate":"2016-03-16","paymentDate":"2016-03-23","value":0.22,"currency":"USD"},{"executeDate":"2016-06-14","recordDate":"2016-06-16","paymentDate":"2016-06-23","value":0.22,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GGT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GGT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GGT","date":"2025-05-08","current":9.078338,"percent":0.776059,"low":-14.341541,"twenty":-1.633559,"median":7.029589,"eighty":9.984084,"high":60.035629,"avg":9.674064,"sd":15.551642,"marketCap":145112859},"quantilePoints":[{"date":"2020-05-15","current":3.074797,"twenty":-6.82,"median":5.219133,"eighty":14.143107,"marketCap":151382971},{"date":"2020-05-22","current":3.348342,"twenty":-6.82,"median":5.208017,"eighty":14.120233,"marketCap":164850577},{"date":"2020-05-29","current":3.469261,"twenty":-6.82,"median":5.202459,"eighty":14.080433,"marketCap":170803812},{"date":"2020-06-05","current":3.772694,"twenty":-6.82,"median":5.191342,"eighty":14.065078,"marketCap":185742921},{"date":"2020-06-12","current":3.590634,"twenty":-6.82,"median":5.174668,"eighty":14.056808,"marketCap":176779456},{"date":"2020-06-19","current":3.428803,"twenty":-6.82,"median":5.13792,"eighty":14.006374,"marketCap":168811931},{"date":"2020-06-26","current":3.312486,"twenty":-6.82,"median":5.121239,"eighty":13.984905,"marketCap":163085273},{"date":"2020-07-02","current":3.302372,"twenty":-6.82,"median":5.113528,"eighty":13.956831,"marketCap":162587302},{"date":"2020-07-10","current":3.2872,"twenty":-6.82,"median":5.080179,"eighty":13.936254,"marketCap":161840347},{"date":"2020-07-17","current":3.282143,"twenty":-6.82,"median":5.063504,"eighty":13.909462,"marketCap":161591362},{"date":"2020-07-24","current":3.347887,"twenty":-6.82,"median":4.963457,"eighty":13.877882,"marketCap":164828169},{"date":"2020-07-31","current":3.484432,"twenty":-6.82,"median":4.935666,"eighty":13.836622,"marketCap":171550768},{"date":"2020-08-07","current":3.529947,"twenty":-6.82,"median":4.885642,"eighty":13.728252,"marketCap":173791634},{"date":"2020-08-14","current":3.636149,"twenty":-6.82,"median":4.868968,"eighty":13.638246,"marketCap":179020322},{"date":"2020-08-21","current":3.590634,"twenty":-6.82,"median":4.842844,"eighty":13.490805,"marketCap":176779456},{"date":"2020-08-28","current":3.641206,"twenty":-6.82,"median":4.807828,"eighty":13.435527,"marketCap":179269308},{"date":"2020-09-04","current":-10.465904,"twenty":-6.830936,"median":4.768921,"eighty":13.403108,"marketCap":179246044},{"date":"2020-09-11","current":-10.275348,"twenty":-10.275348,"median":4.724455,"eighty":13.321901,"marketCap":175982460},{"date":"2020-09-18","current":-9.908895,"twenty":-10.418998,"median":4.57992,"eighty":13.231553,"marketCap":169706338},{"date":"2020-09-25","current":-9.630391,"twenty":-10.418998,"median":4.535348,"eighty":13.161433,"marketCap":164936486},{"date":"2020-10-02","current":-9.410519,"twenty":-10.418998,"median":4.525929,"eighty":13.137642,"marketCap":161170812},{"date":"2020-10-09","current":-9.850263,"twenty":-10.418998,"median":4.497671,"eighty":13.058139,"marketCap":168702159},{"date":"2020-10-16","current":-9.894237,"twenty":-10.418998,"median":4.488252,"eighty":13.006854,"marketCap":169455294},{"date":"2020-10-23","current":-9.71834,"twenty":-10.418998,"median":4.464704,"eighty":12.951075,"marketCap":166442755},{"date":"2020-10-30","current":-9.029407,"twenty":-10.418998,"median":4.455285,"eighty":12.901214,"marketCap":154643646},{"date":"2020-11-06","current":-10.040818,"twenty":-10.418998,"median":4.450575,"eighty":12.805977,"marketCap":171965742},{"date":"2020-11-13","current":-10.436588,"twenty":-10.436588,"median":4.443697,"eighty":12.697121,"marketCap":178743954},{"date":"2020-11-20","current":-10.96428,"twenty":-10.583169,"median":4.436447,"eighty":12.615412,"marketCap":187781570},{"date":"2020-11-27","current":-11.242785,"twenty":-11.140178,"median":4.427027,"eighty":12.550104,"marketCap":192551422},{"date":"2020-12-04","current":-11.990349,"twenty":-11.629827,"median":4.422318,"eighty":12.476062,"marketCap":205354711},{"date":"2020-12-11","current":-11.550606,"twenty":-11.671754,"median":4.403479,"eighty":12.400424,"marketCap":197823365},{"date":"2020-12-18","current":-11.726503,"twenty":-11.687879,"median":4.384641,"eighty":12.340983,"marketCap":200835904},{"date":"2020-12-24","current":-11.620325,"twenty":-11.687879,"median":4.365802,"eighty":12.288473,"marketCap":199017432},{"date":"2020-12-31","current":-11.708581,"twenty":-11.691104,"median":4.351674,"eighty":12.234964,"marketCap":200528956},{"date":"2021-01-08","current":-12.046894,"twenty":-11.720401,"median":4.285739,"eighty":12.153295,"marketCap":206323135},{"date":"2021-01-15","current":-12.032185,"twenty":-11.739481,"median":4.28103,"eighty":12.129308,"marketCap":206071214},{"date":"2021-01-22","current":-12.120441,"twenty":-11.755607,"median":4.265197,"eighty":12.129308,"marketCap":207582739},{"date":"2021-01-29","current":-12.002766,"twenty":-11.787858,"median":4.24453,"eighty":12.129308,"marketCap":205567372},{"date":"2021-02-05","current":-13.032416,"twenty":-11.840018,"median":4.233934,"eighty":12.077737,"marketCap":223201828},{"date":"2021-02-12","current":-13.782588,"twenty":-11.900738,"median":4.224514,"eighty":12.077737,"marketCap":236049789},{"date":"2021-02-19","current":-13.9591,"twenty":-11.948078,"median":4.200966,"eighty":12.077737,"marketCap":239072839},{"date":"2021-02-26","current":-13.75317,"twenty":-11.988552,"median":4.186838,"eighty":11.757918,"marketCap":235545948},{"date":"2021-03-05","current":-13.973809,"twenty":-11.997492,"median":4.121586,"eighty":10.376906,"marketCap":239324760},{"date":"2021-03-12","current":7.678356,"twenty":-11.997492,"median":4.156225,"eighty":10.354298,"marketCap":255673086},{"date":"2021-03-19","current":7.534197,"twenty":-11.965241,"median":4.193902,"eighty":10.354298,"marketCap":250872900},{"date":"2021-03-26","current":7.185181,"twenty":-11.932989,"median":4.215095,"eighty":10.354298,"marketCap":239251396},{"date":"2021-04-01","current":7.329339,"twenty":-11.896764,"median":4.229224,"eighty":10.354298,"marketCap":244051582},{"date":"2021-04-09","current":7.617657,"twenty":-11.801726,"median":4.238643,"eighty":10.354298,"marketCap":253651955},{"date":"2021-04-16","current":7.814927,"twenty":-11.771733,"median":4.253502,"eighty":10.354298,"marketCap":260220631},{"date":"2021-04-23","current":7.670768,"twenty":-11.752709,"median":4.273965,"eighty":10.354298,"marketCap":255420445},{"date":"2021-04-30","current":7.845276,"twenty":-11.723356,"median":4.283385,"eighty":10.354298,"marketCap":261231197},{"date":"2021-05-07","current":7.769403,"twenty":-11.691104,"median":4.327702,"eighty":10.354298,"marketCap":258704783},{"date":"2021-05-14","current":7.564546,"twenty":-11.674979,"median":4.365802,"eighty":10.354298,"marketCap":251883465},{"date":"2021-05-21","current":7.723879,"twenty":-11.638554,"median":4.384641,"eighty":10.354298,"marketCap":257188935},{"date":"2021-05-28","current":7.799753,"twenty":-11.578225,"median":4.403479,"eighty":10.354298,"marketCap":259715348},{"date":"2021-06-04","current":8.148769,"twenty":-11.506631,"median":4.419963,"eighty":10.354298,"marketCap":271336852},{"date":"2021-06-11","current":8.254991,"twenty":-11.140178,"median":4.427027,"eighty":10.354298,"marketCap":274873832},{"date":"2021-06-18","current":7.488673,"twenty":-10.583169,"median":4.436447,"eighty":10.354298,"marketCap":249357051},{"date":"2021-06-25","current":8.133594,"twenty":-10.436588,"median":4.444781,"eighty":10.354298,"marketCap":270831570},{"date":"2021-07-02","current":8.664706,"twenty":-10.26069,"median":4.450575,"eighty":10.354298,"marketCap":288516467},{"date":"2021-07-09","current":8.346039,"twenty":-10.099451,"median":4.455285,"eighty":10.354298,"marketCap":277905529},{"date":"2021-07-16","current":7.333352,"twenty":-10.011502,"median":4.464704,"eighty":10.354298,"marketCap":244185191},{"date":"2021-07-23","current":7.371467,"twenty":-9.894237,"median":4.483543,"eighty":10.354298,"marketCap":245454344},{"date":"2021-07-30","current":7.333352,"twenty":-9.762314,"median":4.497671,"eighty":10.354298,"marketCap":244185191},{"date":"2021-08-06","current":7.279991,"twenty":-9.703681,"median":4.521478,"eighty":10.354298,"marketCap":242408375},{"date":"2021-08-13","current":7.241876,"twenty":-9.630391,"median":4.535348,"eighty":10.354298,"marketCap":241139222},{"date":"2021-08-20","current":7.272368,"twenty":-9.498468,"median":4.575223,"eighty":10.354298,"marketCap":242154545},{"date":"2021-08-27","current":7.165645,"twenty":-9.175989,"median":4.682721,"eighty":10.354298,"marketCap":238600914},{"date":"2021-09-03","current":7.83668,"twenty":-6.820617,"median":4.7717,"eighty":10.354298,"marketCap":260944960},{"date":"2021-09-10","current":7.738312,"twenty":-6.801547,"median":4.805049,"eighty":10.354298,"marketCap":257669501},{"date":"2021-09-17","current":7.566167,"twenty":-6.769577,"median":4.842011,"eighty":10.354298,"marketCap":251937446},{"date":"2021-09-24","current":7.746509,"twenty":-6.75739,"median":4.866189,"eighty":10.354298,"marketCap":257942456},{"date":"2021-10-01","current":7.549772,"twenty":-6.7456,"median":4.882863,"eighty":10.354298,"marketCap":251391536},{"date":"2021-10-08","current":7.582562,"twenty":-6.728847,"median":4.930108,"eighty":10.354298,"marketCap":252483356},{"date":"2021-10-15","current":7.730114,"twenty":-6.721623,"median":4.963457,"eighty":10.354298,"marketCap":257396546},{"date":"2021-10-22","current":7.721917,"twenty":-6.712032,"median":5.041271,"eighty":10.354298,"marketCap":257123591},{"date":"2021-10-29","current":7.500588,"twenty":-6.697645,"median":5.080179,"eighty":10.354298,"marketCap":249753806},{"date":"2021-11-05","current":7.55797,"twenty":-6.68534,"median":5.10797,"eighty":10.354298,"marketCap":251664491},{"date":"2021-11-12","current":7.664536,"twenty":-6.670471,"median":5.121239,"eighty":10.354298,"marketCap":255212906},{"date":"2021-11-19","current":7.771101,"twenty":-6.649691,"median":5.13792,"eighty":10.354298,"marketCap":258761321},{"date":"2021-11-26","current":7.721917,"twenty":-6.641698,"median":5.174668,"eighty":10.354298,"marketCap":257123591},{"date":"2021-12-03","current":7.52518,"twenty":-6.632907,"median":5.185784,"eighty":10.354298,"marketCap":250572671},{"date":"2021-12-10","current":7.377628,"twenty":-6.625178,"median":5.202459,"eighty":10.354298,"marketCap":245659482},{"date":"2021-12-17","current":7.131707,"twenty":-6.60893,"median":5.208017,"eighty":10.354298,"marketCap":237470832},{"date":"2021-12-23","current":7.172694,"twenty":-6.593744,"median":5.215767,"eighty":10.354298,"marketCap":238835607},{"date":"2021-12-31","current":7.115312,"twenty":-6.575242,"median":5.23025,"eighty":10.354298,"marketCap":236924922},{"date":"2022-01-07","current":6.96776,"twenty":-6.565783,"median":5.241079,"eighty":10.354298,"marketCap":232011733},{"date":"2022-01-14","current":7.221878,"twenty":-6.540994,"median":5.246924,"eighty":10.354298,"marketCap":240473337},{"date":"2022-01-21","current":6.533299,"twenty":-6.529805,"median":5.269157,"eighty":10.354298,"marketCap":217545119},{"date":"2022-01-28","current":6.566089,"twenty":-6.521812,"median":5.289722,"eighty":10.354298,"marketCap":218636938},{"date":"2022-02-04","current":6.680852,"twenty":-6.507426,"median":5.32196,"eighty":10.354298,"marketCap":222458308},{"date":"2022-02-11","current":6.713641,"twenty":-6.497835,"median":5.366425,"eighty":10.354298,"marketCap":223550128},{"date":"2022-02-18","current":6.689049,"twenty":-6.445085,"median":5.385879,"eighty":10.354298,"marketCap":222731263},{"date":"2022-02-25","current":7.008746,"twenty":-6.403524,"median":5.402553,"eighty":10.354298,"marketCap":233376507},{"date":"2022-03-04","current":7.098917,"twenty":-6.293229,"median":5.449798,"eighty":10.354298,"marketCap":236379012},{"date":"2022-03-11","current":8.894007,"twenty":1.842855,"median":5.494263,"eighty":10.333952,"marketCap":251271440},{"date":"2022-03-18","current":8.932845,"twenty":1.842855,"median":5.494263,"eighty":10.277433,"marketCap":252368696},{"date":"2022-03-25","current":8.913426,"twenty":1.842855,"median":5.494263,"eighty":10.110136,"marketCap":251820068},{"date":"2022-04-01","current":8.855168,"twenty":1.842855,"median":5.494263,"eighty":9.97449,"marketCap":250174185},{"date":"2022-04-08","current":8.126947,"twenty":1.842855,"median":5.494263,"eighty":9.802672,"marketCap":229600650},{"date":"2022-04-14","current":7.913336,"twenty":1.842855,"median":5.494263,"eighty":9.700938,"marketCap":223565747},{"date":"2022-04-22","current":7.81624,"twenty":1.842855,"median":5.494263,"eighty":9.635376,"marketCap":220822609},{"date":"2022-04-29","current":7.573499,"twenty":1.842855,"median":5.494263,"eighty":9.575607,"marketCap":213964764},{"date":"2022-05-06","current":7.456984,"twenty":1.842855,"median":5.494263,"eighty":9.536271,"marketCap":210672998},{"date":"2022-05-13","current":6.79673,"twenty":1.842855,"median":5.494263,"eighty":9.50771,"marketCap":192019660},{"date":"2022-05-20","current":7.165695,"twenty":1.842855,"median":5.494263,"eighty":9.464552,"marketCap":202443584},{"date":"2022-05-27","current":7.738563,"twenty":1.842855,"median":5.494263,"eighty":9.38217,"marketCap":218628098},{"date":"2022-06-03","current":7.874497,"twenty":1.842855,"median":5.494263,"eighty":9.370866,"marketCap":222468491},{"date":"2022-06-10","current":7.719143,"twenty":1.842855,"median":5.494263,"eighty":9.280436,"marketCap":218079471},{"date":"2022-06-17","current":6.631667,"twenty":1.842855,"median":5.494263,"eighty":9.232959,"marketCap":187356325},{"date":"2022-06-24","current":7.253082,"twenty":1.814535,"median":5.491484,"eighty":9.212613,"marketCap":204912408},{"date":"2022-07-01","current":7.107438,"twenty":1.814535,"median":5.491484,"eighty":9.185753,"marketCap":200797701},{"date":"2022-07-08","current":7.146276,"twenty":1.814535,"median":5.491484,"eighty":9.165136,"marketCap":201894956},{"date":"2022-07-15","current":6.728763,"twenty":1.814535,"median":5.491484,"eighty":9.126704,"marketCap":190099463},{"date":"2022-07-22","current":6.854988,"twenty":1.814535,"median":5.491484,"eighty":9.075272,"marketCap":193665542},{"date":"2022-07-29","current":6.913245,"twenty":1.814535,"median":5.491484,"eighty":8.986537,"marketCap":195311425},{"date":"2022-08-05","current":7.04918,"twenty":1.814535,"median":5.491484,"eighty":8.931148,"marketCap":199151818},{"date":"2022-08-12","current":7.340468,"twenty":1.814535,"median":5.491484,"eighty":8.913426,"marketCap":207381232},{"date":"2022-08-19","current":7.476403,"twenty":1.814535,"median":5.491484,"eighty":8.882355,"marketCap":211221626},{"date":"2022-08-26","current":7.03947,"twenty":1.814535,"median":5.497042,"eighty":8.845819,"marketCap":198877505},{"date":"2022-09-02","current":7.097728,"twenty":1.814535,"median":6.533299,"eighty":8.845819,"marketCap":200523387},{"date":"2022-09-09","current":7.612061,"twenty":1.814535,"median":6.598878,"eighty":8.845819,"marketCap":215054215},{"date":"2022-09-16","current":7.066254,"twenty":1.814535,"median":6.670505,"eighty":8.845819,"marketCap":199634194},{"date":"2022-09-23","current":6.111092,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":172649158},{"date":"2022-09-30","current":6.091598,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":172098443},{"date":"2022-10-07","current":6.140331,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":173475231},{"date":"2022-10-14","current":6.003879,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":169620226},{"date":"2022-10-21","current":5.828441,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":164663790},{"date":"2022-10-28","current":6.042866,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":170721656},{"date":"2022-11-04","current":5.760215,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":162736288},{"date":"2022-11-11","current":6.023373,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":170170941},{"date":"2022-11-18","current":5.91616,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":167142008},{"date":"2022-11-25","current":5.994133,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":169344868},{"date":"2022-12-02","current":6.422981,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":181460599},{"date":"2022-12-09","current":5.877174,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":166040578},{"date":"2022-12-16","current":5.730976,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":161910215},{"date":"2022-12-23","current":5.594524,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":158055210},{"date":"2022-12-30","current":5.214408,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":147316267},{"date":"2023-01-06","current":5.682243,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":160533428},{"date":"2023-01-13","current":5.428833,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":153374133},{"date":"2023-01-20","current":5.487312,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":155026278},{"date":"2023-01-27","current":5.458072,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":154200205},{"date":"2023-02-03","current":5.604271,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":158330568},{"date":"2023-02-10","current":5.360607,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":151446630},{"date":"2023-02-17","current":5.799202,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":163837718},{"date":"2023-02-24","current":5.63351,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":159156640},{"date":"2023-03-03","current":5.867428,"twenty":1.814535,"median":6.686138,"eighty":8.845819,"marketCap":165765221},{"date":"2023-03-10","current":-1.789539,"twenty":-1.796794,"median":6.686138,"eighty":8.845819,"marketCap":164004767},{"date":"2023-03-17","current":-1.63235,"twenty":-1.81614,"median":6.686138,"eighty":8.845819,"marketCap":149598943},{"date":"2023-03-24","current":-1.71699,"twenty":-1.81614,"median":6.686138,"eighty":8.845819,"marketCap":157355925},{"date":"2023-03-31","current":-1.704899,"twenty":-1.811908,"median":6.683495,"eighty":8.842703,"marketCap":156247785},{"date":"2023-04-06","current":-1.707921,"twenty":-1.811908,"median":6.683495,"eighty":8.842703,"marketCap":156524820},{"date":"2023-04-14","current":-1.726577,"twenty":-1.81614,"median":6.686138,"eighty":8.845819,"marketCap":158234490},{"date":"2023-04-21","current":-1.705336,"twenty":-1.81614,"median":6.686138,"eighty":8.845819,"marketCap":156287844},{"date":"2023-04-28","current":-1.73568,"twenty":-1.81614,"median":6.686138,"eighty":8.845819,"marketCap":159068767},{"date":"2023-05-05","current":-1.690164,"twenty":-1.81614,"median":6.686138,"eighty":8.845819,"marketCap":154897383},{"date":"2023-05-12","current":-1.699267,"twenty":-1.81614,"median":6.686138,"eighty":8.845819,"marketCap":155731660},{"date":"2023-05-19","current":-1.823678,"twenty":-1.825741,"median":6.686138,"eighty":8.845819,"marketCap":167133442},{"date":"2023-05-26","current":-1.81154,"twenty":-1.826773,"median":6.687594,"eighty":8.848936,"marketCap":166021073},{"date":"2023-06-02","current":-1.83885,"twenty":-1.834844,"median":6.687594,"eighty":8.848936,"marketCap":168523903},{"date":"2023-06-09","current":-1.878297,"twenty":-1.867373,"median":6.687594,"eighty":8.848936,"marketCap":172139102},{"date":"2023-06-16","current":-1.896503,"twenty":-1.942626,"median":6.687594,"eighty":8.848936,"marketCap":173807656},{"date":"2023-06-23","current":-2.036086,"twenty":-2.026983,"median":6.689049,"eighty":8.852052,"marketCap":186599899},{"date":"2023-06-30","current":-2.008776,"twenty":-2.057327,"median":6.689049,"eighty":8.855168,"marketCap":184097069},{"date":"2023-07-07","current":-2.014845,"twenty":-2.057327,"median":6.689049,"eighty":8.855168,"marketCap":184653254},{"date":"2023-07-14","current":-2.033051,"twenty":-2.057327,"median":6.689049,"eighty":8.855168,"marketCap":186321807},{"date":"2023-07-21","current":-2.033051,"twenty":-2.057327,"median":6.689049,"eighty":8.855168,"marketCap":186321807},{"date":"2023-07-28","current":-1.966295,"twenty":-2.057327,"median":6.689049,"eighty":8.855168,"marketCap":180203778},{"date":"2023-08-04","current":-1.896503,"twenty":-2.057327,"median":6.689049,"eighty":8.855168,"marketCap":173807656},{"date":"2023-08-11","current":-1.911675,"twenty":-2.057327,"median":6.689049,"eighty":8.855168,"marketCap":175198117},{"date":"2023-08-18","current":-1.832781,"twenty":-2.057327,"median":6.689049,"eighty":8.855168,"marketCap":167967719},{"date":"2023-08-25","current":-1.756921,"twenty":-2.057327,"median":6.689049,"eighty":8.855168,"marketCap":161015412},{"date":"2023-09-01","current":-1.932916,"twenty":-2.057327,"median":6.683495,"eighty":8.835749,"marketCap":177144763},{"date":"2023-09-08","current":57.482715,"twenty":-2.057327,"median":6.663382,"eighty":8.81633,"marketCap":175198117},{"date":"2023-09-15","current":55.734296,"twenty":-2.057327,"median":6.663382,"eighty":8.81633,"marketCap":169869216},{"date":"2023-09-22","current":56.008849,"twenty":-2.057327,"median":6.663382,"eighty":8.81633,"marketCap":170706010},{"date":"2023-09-29","current":53.263317,"twenty":-2.057327,"median":6.663382,"eighty":8.81633,"marketCap":162338068},{"date":"2023-10-06","current":53.629388,"twenty":-2.057327,"median":6.663382,"eighty":8.81633,"marketCap":163453794},{"date":"2023-10-13","current":54.178494,"twenty":-2.057327,"median":6.663382,"eighty":8.81633,"marketCap":165127382},{"date":"2023-10-20","current":51.52448,"twenty":-2.057327,"median":6.663382,"eighty":8.81633,"marketCap":157038372},{"date":"2023-10-27","current":46.216452,"twenty":-4.5442,"median":6.639865,"eighty":8.725386,"marketCap":140860351},{"date":"2023-11-03","current":43.745474,"twenty":-4.5442,"median":6.639865,"eighty":8.742246,"marketCap":133329204},{"date":"2023-11-10","current":39.901729,"twenty":-4.5442,"median":6.639865,"eighty":8.742246,"marketCap":121614086},{"date":"2023-11-17","current":43.928509,"twenty":-4.5442,"median":6.639865,"eighty":8.742246,"marketCap":133887067},{"date":"2023-11-24","current":48.138325,"twenty":-4.5442,"median":6.639865,"eighty":8.742246,"marketCap":146717911},{"date":"2023-12-01","current":49.602608,"twenty":-4.5442,"median":6.639865,"eighty":8.742246,"marketCap":151180813},{"date":"2023-12-08","current":55.55126,"twenty":-3.715242,"median":6.648062,"eighty":8.787201,"marketCap":169311353},{"date":"2023-12-15","current":51.52448,"twenty":-4.5442,"median":6.639865,"eighty":8.742246,"marketCap":157038372},{"date":"2023-12-22","current":52.34814,"twenty":-6.202115,"median":6.631667,"eighty":8.81633,"marketCap":159548755},{"date":"2023-12-29","current":51.799033,"twenty":-6.2181,"median":6.627569,"eighty":8.855168,"marketCap":157875166},{"date":"2024-01-05","current":51.15841,"twenty":-6.234085,"median":6.62347,"eighty":8.882355,"marketCap":155922647},{"date":"2024-01-12","current":50.609303,"twenty":-6.234085,"median":6.62347,"eighty":8.913426,"marketCap":154249058},{"date":"2024-01-19","current":49.419573,"twenty":-6.25007,"median":6.615818,"eighty":8.913426,"marketCap":150622950},{"date":"2024-01-26","current":49.419573,"twenty":-6.234085,"median":6.62347,"eighty":8.913426,"marketCap":150622950},{"date":"2024-02-02","current":50.517785,"twenty":-6.234085,"median":6.62347,"eighty":8.913426,"marketCap":153970127},{"date":"2024-02-09","current":49.51109,"twenty":-6.234085,"median":6.62347,"eighty":8.913426,"marketCap":150901881},{"date":"2024-02-16","current":49.328055,"twenty":-6.234085,"median":6.62347,"eighty":8.913426,"marketCap":150344019},{"date":"2024-02-23","current":50.243232,"twenty":-6.234085,"median":6.62347,"eighty":8.913426,"marketCap":153133333},{"date":"2024-03-01","current":51.15841,"twenty":-6.2181,"median":6.627569,"eighty":8.915368,"marketCap":155922647},{"date":"2024-03-08","current":53.354835,"twenty":-2.886285,"median":6.635766,"eighty":8.925078,"marketCap":162617000},{"date":"2024-03-15","current":6.824609,"twenty":-2.037907,"median":6.687594,"eighty":8.925078,"marketCap":158897877},{"date":"2024-03-22","current":7.113992,"twenty":-2.024555,"median":6.709542,"eighty":8.925078,"marketCap":165635597},{"date":"2024-03-28","current":6.824609,"twenty":-2.015452,"median":6.745368,"eighty":8.925078,"marketCap":158897877},{"date":"2024-04-05","current":6.836667,"twenty":-1.997853,"median":6.767601,"eighty":8.92702,"marketCap":159178616},{"date":"2024-04-12","current":6.547284,"twenty":-1.978432,"median":6.79673,"eighty":8.92702,"marketCap":152440896},{"date":"2024-04-19","current":6.36642,"twenty":-1.943233,"median":6.79673,"eighty":8.92702,"marketCap":148229822},{"date":"2024-04-26","current":6.523169,"twenty":-1.918351,"median":6.792583,"eighty":8.925078,"marketCap":151879420},{"date":"2024-05-03","current":6.559342,"twenty":-1.90682,"median":6.792583,"eighty":8.925078,"marketCap":152721635},{"date":"2024-05-10","current":6.728148,"twenty":-1.89711,"median":6.792583,"eighty":8.925078,"marketCap":156651971},{"date":"2024-05-17","current":6.87284,"twenty":-1.880118,"median":6.806252,"eighty":8.925078,"marketCap":160020831},{"date":"2024-05-24","current":6.993416,"twenty":-1.833995,"median":6.816149,"eighty":8.925078,"marketCap":162828214},{"date":"2024-05-31","current":6.704033,"twenty":-1.827137,"median":6.8236,"eighty":8.925078,"marketCap":156090494},{"date":"2024-06-07","current":6.969301,"twenty":-1.812147,"median":6.825859,"eighty":8.925078,"marketCap":162266737},{"date":"2024-06-14","current":6.824609,"twenty":-1.798796,"median":6.844799,"eighty":8.92702,"marketCap":158897877},{"date":"2024-06-21","current":6.450823,"twenty":-1.789995,"median":6.845039,"eighty":8.928961,"marketCap":150194990},{"date":"2024-06-28","current":6.535227,"twenty":-1.762464,"median":6.854988,"eighty":8.934787,"marketCap":152160158},{"date":"2024-07-05","current":6.330247,"twenty":-1.742963,"median":6.854988,"eighty":8.934787,"marketCap":147387607},{"date":"2024-07-12","current":6.101152,"twenty":-1.724149,"median":6.854988,"eighty":8.934787,"marketCap":142053579},{"date":"2024-07-15","current":6.077037,"twenty":-1.723542,"median":6.854988,"eighty":8.934787,"marketCap":141492103},{"date":"2024-08-02","current":6.034836,"twenty":-1.70837,"median":6.875998,"eighty":8.952264,"marketCap":140509519},{"date":"2024-08-09","current":5.996918,"twenty":-1.705249,"median":6.875998,"eighty":8.952264,"marketCap":139626674},{"date":"2024-08-16","current":5.741988,"twenty":-1.699267,"median":6.875998,"eighty":8.952264,"marketCap":133691127},{"date":"2024-08-23","current":5.978708,"twenty":-1.692591,"median":6.875998,"eighty":8.952264,"marketCap":139202706},{"date":"2024-08-30","current":6.215429,"twenty":-1.658951,"median":6.875998,"eighty":8.952264,"marketCap":144714286},{"date":"2024-09-06","current":6.154731,"twenty":-1.628722,"median":6.873623,"eighty":8.950322,"marketCap":143301060},{"date":"2024-09-13","current":21.224885,"twenty":-1.628722,"median":6.873623,"eighty":8.950322,"marketCap":144148995},{"date":"2024-09-20","current":20.33011,"twenty":-1.628722,"median":6.873623,"eighty":8.950322,"marketCap":138072126},{"date":"2024-09-27","current":20.600623,"twenty":-1.628722,"median":6.873623,"eighty":8.950322,"marketCap":139909319},{"date":"2024-10-04","current":20.392536,"twenty":-1.628722,"median":6.873623,"eighty":8.950322,"marketCap":138496094},{"date":"2024-10-11","current":19.68504,"twenty":-1.628722,"median":6.873623,"eighty":8.950322,"marketCap":133691127},{"date":"2024-10-18","current":19.768275,"twenty":-1.628722,"median":6.873623,"eighty":8.950322,"marketCap":134256417},{"date":"2024-10-25","current":19.102396,"twenty":-1.628722,"median":6.873623,"eighty":8.950322,"marketCap":129734096},{"date":"2024-10-31","current":19.289675,"twenty":-1.628722,"median":6.873623,"eighty":8.950322,"marketCap":131005999},{"date":"2024-11-08","current":19.976778,"twenty":-1.63235,"median":6.87284,"eighty":8.942555,"marketCap":135672469},{"date":"2024-11-15","current":19.893127,"twenty":-1.63235,"median":6.87284,"eighty":8.942555,"marketCap":135104353},{"date":"2024-11-22","current":20.101214,"twenty":-1.63235,"median":6.87284,"eighty":8.942555,"marketCap":136517578},{"date":"2024-11-29","current":20.767093,"twenty":-1.63235,"median":6.87284,"eighty":8.942555,"marketCap":141039899},{"date":"2024-12-06","current":20.97518,"twenty":-1.63235,"median":6.87284,"eighty":8.942555,"marketCap":142453125},{"date":"2024-12-13","current":21.016798,"twenty":-1.63235,"median":6.87284,"eighty":8.942555,"marketCap":142735770},{"date":"2024-12-20","current":19.393718,"twenty":-1.63235,"median":6.87284,"eighty":8.942555,"marketCap":131712611},{"date":"2024-12-27","current":19.185631,"twenty":-1.63235,"median":6.87284,"eighty":8.942555,"marketCap":130299386},{"date":"2025-01-03","current":18.686222,"twenty":-1.63235,"median":6.87284,"eighty":8.942555,"marketCap":126907645},{"date":"2025-01-10","current":19.211434,"twenty":-1.632955,"median":6.87284,"eighty":8.934787,"marketCap":130474626},{"date":"2025-01-17","current":19.601805,"twenty":-1.632955,"median":6.87284,"eighty":8.934787,"marketCap":133125837},{"date":"2025-01-24","current":20.01798,"twenty":-1.632955,"median":6.87284,"eighty":8.934787,"marketCap":135952288},{"date":"2025-01-31","current":20.350919,"twenty":-1.632955,"median":6.87284,"eighty":8.934787,"marketCap":138213449},{"date":"2025-02-07","current":20.392536,"twenty":-1.632955,"median":6.87284,"eighty":8.934787,"marketCap":138496094},{"date":"2025-02-14","current":20.01798,"twenty":-1.632955,"median":6.87284,"eighty":8.934787,"marketCap":135952288},{"date":"2025-02-21","current":19.891879,"twenty":-1.632955,"median":6.87284,"eighty":8.934787,"marketCap":135095873},{"date":"2025-02-28","current":19.955553,"twenty":-1.632955,"median":6.87284,"eighty":8.934787,"marketCap":135528320},{"date":"2025-03-07","current":19.976362,"twenty":-1.633559,"median":6.87284,"eighty":8.936729,"marketCap":135669643},{"date":"2025-03-14","current":8.595251,"twenty":-1.633559,"median":6.885786,"eighty":8.952264,"marketCap":137390951},{"date":"2025-03-21","current":9.767039,"twenty":-1.633559,"median":6.913245,"eighty":9.854567,"marketCap":156121421},{"date":"2025-03-28","current":9.850518,"twenty":-1.633559,"median":6.926773,"eighty":9.984084,"marketCap":157455792},{"date":"2025-04-04","current":9.412253,"twenty":-1.633559,"median":6.951365,"eighty":9.984084,"marketCap":150450343},{"date":"2025-04-11","current":8.932249,"twenty":-1.632955,"median":6.96776,"eighty":9.97991,"marketCap":142777709},{"date":"2025-04-17","current":9.224426,"twenty":-1.632955,"median":6.981286,"eighty":9.97991,"marketCap":147448008},{"date":"2025-04-25","current":9.746169,"twenty":-1.633559,"median":6.993416,"eighty":9.984084,"marketCap":155787828},{"date":"2025-05-02","current":9.287035,"twenty":-1.633559,"median":7.008746,"eighty":9.984084,"marketCap":148448787},{"date":"2025-05-08","current":9.078338,"twenty":-1.633559,"median":7.029589,"eighty":9.984084,"marketCap":145112859}],"updateTime":1746847604655}}}